• Policies related to health care and access to services for children and youth with special health care needs Support for caregivers Policies related to school-based seizure protections for kids with epilepsy
• Appropriations for the CDC
• Medicaid unwinding, the process for redetermination of Medicaid eligibility Preserving and expanding access to Medicaid Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Policies related to prior authorization, including step therapy Policies related to implementation of the Inflation Reduction Act, including implementation of Medicare drug negotiation program and the orphan drug exclusion Comments Re: Medicaid; CMS Enforcement of State Compliance with Reporting and Federal Medicaid Renewal Requirements Under Section 1902(t) of the Social Security Act (CMS-2447-IFC) Comments RE: Notice of Benefit and Payment Parameters for 2025 Proposed Rule (CMS-9895-P).
• Support for policies which ensure health insurance provides comprehensive benefits and is affordable and accessible for patients Patient Priorities for the Notice of Benefit and Payment Parameters HR 824, the Telehealth Benefit Expansion for Workers Act Comments related to the Mental Health Parity and Addiction Equity Act

Duration: September 15, 2020 to February 8, 2024

General Issues: Health Issues, Budget/Appropriations, Medicare/Medicaid, Insurance, Medical/Disease Research/Clinical Labs

Spending: about $327,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2020: U.S. Senate, House of Representatives, Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), White House Office, Labor - Dept of (DOL), Treasury - Dept of, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Internal Revenue Service (IRS), Agency for Healthcare Research & Quality (AHRQ), Office of Science & Technology Policy (OSTP), Office of Management & Budget (OMB)